Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen-Reference-Cited by-同舟云学术

Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen

Published:2012-04-16 Issue:4 Volume:8 Page:470-478
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Shin Thomas,Pankhong Panyupa,Yan Jian,Khan Amir S,Sardesai Niranjan Y,Weiner David B.

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.19180

Reference27 articles.

1. WHO/ICO HPV Information Centre. Human Papillomavirus and Related Cancers in World. Summary Report 2010. WHO. [ www. who. int/hpvcentre] Accessed on 8 July 2011.

2. Against which human papillomavirus types shall we vaccinate and screen? the international perspective

3. Malignant transformation of a highly aggressive human papillomavirus type 11–associated recurrent respiratory papillomatosis

4. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11

5. The role of HPV type in Recurrent Respiratory Papillomatosis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of the Antigenic Protein HPV6 L1 to Induce the Synthesis of Interferon, CD4 and CD8 T Lymphocytes, and Granzyme B in Blood and Splenocytes of Mice in Order to Develop a Broad Vaccine against Anogenital Papillomatoses;Doklady Biochemistry and Biophysics;2021-09

2. Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update;Expert Opinion on Pharmacotherapy;2021-07-05

3. The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits;Doklady Biochemistry and Biophysics;2021-05

4. Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis;Vaccines;2020-01-29

5. Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes;Cancers;2019-01-24